Volume 62, Issue 2, Pages 688-696 (August 2002) Recombinant human growth hormone post-renal transplantation in children: A randomized controlled study of the NAPRTCS Richard N. Fine M.D., Donald Stablein, Arthur H. Cohen, Amir Tejani, Edward Kohaut Kidney International Volume 62, Issue 2, Pages 688-696 (August 2002) DOI: 10.1046/j.1523-1755.2002.00489.x Copyright © 2002 International Society of Nephrology Terms and Conditions
Figure 1 One-year study results according to treatment group. Data are means ± SE. Symbols are: (dashed line) rhGH-treated with Neutropin; (solid line) controls. (A) Growth velocity (P < 0.001). (B) Height SDS (standardized height score; P < 0.03). (C) Changes in height SDS (P < 0.001). (D) Changes in height (P < 0.001). Kidney International 2002 62, 688-696DOI: (10.1046/j.1523-1755.2002.00489.x) Copyright © 2002 International Society of Nephrology Terms and Conditions
Figure 2 Change in height according to treatment group. Symbols are: (dashed line) rhGH-treated with Neutropin; (solid line) controls. Whiskers denote the SE. Kidney International 2002 62, 688-696DOI: (10.1046/j.1523-1755.2002.00489.x) Copyright © 2002 International Society of Nephrology Terms and Conditions
Figure 3 Serum creatinine values over time. Symbols are: (dashed line) rhGH-treated with Neutropin; (solid line) controls. Data are mean ± SE, P = NS. Kidney International 2002 62, 688-696DOI: (10.1046/j.1523-1755.2002.00489.x) Copyright © 2002 International Society of Nephrology Terms and Conditions